Literature DB >> 21801701

Chimeric mouse model of hepatitis B virus infection.

Maura Dandri1, Jörg Petersen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21801701     DOI： 10.1016/j.jhep.2011.05.037

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  12 in total

1.  Identification of disubstituted sulfonamide compounds as specific inhibitors of hepatitis B virus covalently closed circular DNA formation.

Authors:  Dawei Cai; Courtney Mills; Wenquan Yu; Ran Yan; Carol E Aldrich; Jeffry R Saputelli; William S Mason; Xiaodong Xu; Ju-Tao Guo; Timothy M Block; Andrea Cuconati; Haitao Guo
Journal:  Antimicrob Agents Chemother       Date:  2012-05-29       Impact factor: 5.191

2.  Lymphocytes transiently expressing virus-specific T cell receptors reduce hepatitis B virus infection.

Authors:  Janine Kah; Sarene Koh; Tassilo Volz; Erica Ceccarello; Lena Allweiss; Marc Lütgehetmann; Antonio Bertoletti; Maura Dandri
Journal:  J Clin Invest       Date:  2017-07-24       Impact factor: 14.808

3.  Viral hepatitis: The bumpy road to animal models for HBV infection.

Authors:  Ulrike Protzer
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-04-12       Impact factor: 46.802

4.  Human stem cell-derived hepatocytes as a model for hepatitis B virus infection, spreading and virus-host interactions.

Authors:  Yuchen Xia; Arnaud Carpentier; Xiaoming Cheng; Peter Daniel Block; Yao Zhao; Zhensheng Zhang; Ulrike Protzer; T Jake Liang
Journal:  J Hepatol       Date:  2016-10-14       Impact factor: 25.083

Review 5.  Experimental models and therapeutic approaches for HBV.

Authors:  Maura Dandri; Marc Lütgehetmann; Jörg Petersen
Journal:  Semin Immunopathol       Date:  2012-08-17       Impact factor: 9.623

Review 6.  Targeted DNA mutagenesis for the cure of chronic viral infections.

Authors:  Joshua T Schiffer; Martine Aubert; Nicholas D Weber; Esther Mintzer; Daniel Stone; Keith R Jerome
Journal:  J Virol       Date:  2012-06-20       Impact factor: 5.103

Review 7.  Current progress in the development of therapeutic vaccines for chronic hepatitis B virus infection.

Authors:  Faezeh Ghasemi; Sina Rostami; Majid Ghayour-Mobarhan; Zahra Meshkat
Journal:  Iran J Basic Med Sci       Date:  2016-07       Impact factor: 2.699

Review 8.  Advances and Challenges in Studying Hepatitis B Virus In Vitro.

Authors:  Dvora Witt-Kehati; Maya Bitton Alaluf; Amir Shlomai
Journal:  Viruses       Date:  2016-01-14       Impact factor: 5.048

9.  T cell--associated immunoregulation and antiviral effect of oxymatrine in hydrodynamic injection HBV mouse model.

Authors:  Xiuxiu Sang; Ruilin Wang; Yanzhong Han; Cong'en Zhang; Honghui Shen; Zhirui Yang; Yin Xiong; Huimin Liu; Shijing Liu; Ruisheng Li; Ruichuang Yang; Jiabo Wang; Xuejun Wang; Zhaofang Bai; Xiaohe Xiao
Journal:  Acta Pharm Sin B       Date:  2017-05-02       Impact factor: 11.413

10.  A Chimeric Humanized Mouse Model by Engrafting the Human Induced Pluripotent Stem Cell-Derived Hepatocyte-Like Cell for the Chronic Hepatitis B Virus Infection.

Authors:  Lunzhi Yuan; Xuan Liu; Liang Zhang; Xiaoling Li; Yali Zhang; Kun Wu; Yao Chen; Jiali Cao; Wangheng Hou; Jun Zhang; Hua Zhu; Quan Yuan; Qiyi Tang; Tong Cheng; Ningshao Xia
Journal:  Front Microbiol       Date:  2018-05-08       Impact factor: 5.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.